Biophytis Gives Operational Perspectives on its Sarconeos (BIO101) Ahead of its Upcoming AGM …,

Biophytis now intends to resume the preparation for launching the MYODA Phase 1/2 clinical trial of Sarconeos (BIO101) in Duchenne Muscular …, Biophytis now intends to resume the preparation for launching the MYODA Phase 1/2 clinical trial of Sarconeos (BIO101) in Duchenne Muscular …, Read More

Scroll to Top